|
1
|
de Lecea L, Criado JR, Prospero-Garcia O,
Gautvik KM, Schweitzer P, Danielson PE, Dunlop CL, Siggins GR,
Henriksen SJ and Sutcliffe JG: A cortical neuropeptide with
neuronal depressant and sleep-modulating properties. Nature.
381:242–245. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Spier AD and de Lecea L: Cortistatin: A
member of the somatostatin neuropeptide family with distinct
physiological functions. Brain Res Brain Res Rev. 33:228–241. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siehler S, Seuwen K and Hoyer D:
[125I]Tyr10-cortistatin14 labels all five somatostatin receptors.
Naunyn Schmiedebergs Arch Pharmacol. 357:483–489. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dello Russo C, Lisi L, Navarra P and
Tringali G: Diverging effects of cortistatin and somatostatin on
the production and release of prostanoids from rat cortical
microglia and astrocytes. J Neuroimmunol. 213:78–83. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Córdoba-Chacón J, Gahete MD, Pozo-Salas
AI, Martínez-Fuentes AJ, de Lecea L, Gracia-Navarro F, Kineman RD,
Castaño JP and Luque RM: Cortistatin is not a somatostatin analogue
but stimulates prolactin release and inhibits GH and ACTH in a
gender-dependent fashion: Potential role of ghrelin. Endocrinology.
152:4800–4812. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Córdoba-Chacón J, Gahete MD, Durán-Prado
M, Luque RM and Castaño JP: Truncated somatostatin receptors as new
players in somatostatin-cortistatin pathophysiology. Ann N Y Acad
Sci. 1220:6–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Markovics A, Szoke É, Sándor K, Börzsei R,
Bagoly T, Kemény Á, Elekes K, Pintér E, Szolcsányi J and Helyes Z:
Comparison of the anti-inflammatory and anti-nociceptive effects of
Cortistatin-14 and Somatostatin-14 in distinct in vitro and in vivo
model systems. J Mol Neurosci. 46:40–50. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tringali G, Greco MC, Lisi L, Pozzoli G
and Navarra P: Cortistatin modulates the expression and release of
corticotrophin releasing hormone in rat brain. Comparison with
somatostatin and octreotide. Peptides. 34:353–359. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Delgado M and Gonzalez-Rey E: Role of
cortistatin in the stressed immune system. Front Horm Res.
48:110–120. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dalm VA, Van Hagen PM, de Krijger RR, Kros
JM, Van Koetsveld PM, van der Lely AJ, Lamberts SW and Hofland LJ:
Distribution pattern of somatostatin and cortistatin mRNA in human
central and peripheral tissues. Clin Endocrinol (Oxf). 60:625–629.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Carrasco E, Hernández C, Miralles A,
Huguet P, Farrés J and Simó R: Lower somatostatin expression is an
early event in diabetic retinopathy and is associated with retinal
neurodegeneration. Diabetes Care. 30:2902–2908. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carrasco E, Hernández C, de Torres I,
Farrés J and Simó R: Lowered cortistatin expression is an early
event in the human diabetic retina and is associated with apoptosis
and glial activation. Mol Vis. 14:1496–1502. 2008.PubMed/NCBI
|
|
13
|
Vasilaki A and Thermos K: Somatostatin
analogues as therapeutics in retinal disease. Pharmacol Ther.
122:324–333. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mastrodimou N, Lambrou GN and Thermos K:
Effect of somatostatin analogues on chemically induced ischaemia in
the rat retina. Naunyn Schmiedebergs Arch Pharmacol. 371:44–53.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Roduit R and Schorderet DF: MAP kinase
pathways in UV-induced apoptosis of retinal pigment epithelium
ARPE19 cells. Apoptosis. 13:343–353. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hanus J, Zhang H, Wang Z, Liu Q, Zhou Q
and Wang S: Induction of necrotic cell death by oxidative stress in
retinal pigment epithelial cells. Cell Death Dis. 4:e9652013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tringali G, Sampaolese B and Clementi ME:
Expression of early and late cellular damage markers by ARPE-19
cells following prolonged treatment with UV-A radiation. Mol Med
Rep. 14:3485–3489. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barltrop JA, Owen TC, Cory AH and Cory JG:
5-(3-Carboxylmethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl)
tetrazolium, inner salt (MTS) and related analogs of
3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT)
reducing to purple water-soluble formazans as cell-viability
indicators. Bioorg Med Chem Lett. 1:611–614. 1991. View Article : Google Scholar
|
|
19
|
Delgado-Maroto V, Benitez R, Forte-Lago I,
Morell M, Maganto-Garcia E, Souza-Moreira L, O'Valle F, Duran-Prado
M, Lichtman AH, Gonzalez-Rey E and Delgado M: Cortistatin reduces
atherosclerosis in hyperlipidemic ApoE-deficient mice and the
formation of foam cells. Sci Rep. 7:464442017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gonzalez-Rey E, Pedreño M, Delgado-Maroto
V, Souza-Moreira L and Delgado M: Lulling immunity, pain, and
stress to sleep with cortistatin. Ann N Y Acad Sci. 1351:89–98.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Klisovic DD, O'Dorisio MS, Katz SE, Sall
JW, Balster D, O'Dorisio TM, Craig E and Lubow M: Somatostatin
receptor gene expression in human ocular tissues: RT-PCR and
immunohistochemical study. Invest Ophthalmol Vis Sci. 42:2193–2201.
2001.PubMed/NCBI
|
|
22
|
Sall JW, Klisovic DD, O'Dorisio MS and
Katz SE: Somatostatin inhibits IGF-1 mediated induction of VEGF in
human retinal pigment epithelial cells. Exp Eye Res. 79:465–476.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Papadaki T, Tsilimbaris M, Pallikaris I
and Thermos K: Somatostatin receptor activation (sst(1)-sst(5))
differentially influences human retinal pigment epithelium cell
viability. Acta Ophthalmol. 88:e228–e233. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vasilaki A, Papadaki T, Notas G, Kolios G,
Mastrodimou N, Hoyer D, Tsilimbaris M, Kouroumalis E, Pallikaris I
and Thermos K: Effect of somatostatin on nitric oxide production in
human retinal pigment epithelium cell cultures. Invest Ophthalmol
Vis Sci. 45:1499–1506. 2004. View Article : Google Scholar : PubMed/NCBI
|
